Biomedical subjects

Suphi Taneri

Publications and source records attributed to Suphi Taneri.

7 recordsLinked to original sources

PubMed2006

Laser in situ keratomileusis flap thickness using the Hansatome microkeratome with zero compression heads.

PURPOSE: To evaluate predictability and possible factors affecting flap thickness in laser in situ keratomileusis (LASIK) using the Hansatome microkeratome (Bausch & Lomb Surgical) with zero compression heads. SETTING: Zentrum für Refraktive Chirurgie Münster, Münster, Germany. METHODS: A prospective nonrandomized comparative (self-controlled) trial analyzing flap thickness in 153 consecutive patients having LASIK using the Hansatome microkeratome with zero compression was conducted. Two hundred thirty-eight eyes that had uncomplicated primary LASIK (n = 237) or secondary LASIK (n = 1) by the same surgeon and same technique using 4 different microkeratomes of the same model were evaluated. Each keratome cut was performed with a new Accuglide (Bausch & Lomb) blade in a 160 microm (n = 89), 180 microm (n = 128), or 200 microm (n = 21) Hansatome zero compression head coupled to a 8.5 mm (n = 106) or 9.5 mm (n = 131) suction ring. Only Hansatome elements with the same serial numbers were combined. Ultrasound subtraction pachymetry was routinely used to determine intraoperative flap thickness. Flap thickness was correlated with microkeratome head dimension, suction ring size, preoperative keratometry obtained by Orbscan IIz (Bausch & Lomb), preoperative corneal thickness as obtained by ultrasound pachymetry, refractive error, and age. RESULTS: Measured intraoperative flap thickness was significantly different (P<.01) from predicted flap thickness. The mean flap thickness was 97 microm +/- 18 (SD) (range 65 to 163 microm), 111 +/- 20 microm (range 61 to 177 microm), and 131 +/- 20 microm (range 89 to 162 microm) for the 160 microm, the 180 microm, and 200 microm heads, respectively. There was a good correlation between microkeratome head and corneal flap thickness. However, there was a variability between devices. There was a low correlation between baseline ultrasound pachymetry at the time of surgery and corneal flap thickness (r = .26) and a small effect of ring size. There was no correlation with keratometry, refractive error, or age. CONCLUSIONS: There was a remarkable difference in the flap thickness of microkeratomes of the same make and model. This emphasizes the need to measure intraoperative flap thickness and to evaluate every microkeratome separately. Factors affecting flap thickness seem to be more device dependent than patient related; obtaining flap thickness in the first eye did not enable predictions of the flap thickness in the fellow eye.

Adult↗

PubMed2006

Epi-LASIK after amputation of a LASIK flap.

PURPOSE: To demonstrate the feasibility of performing epi-LASIK after amputation of a LASIK flap. METHODS: Three months following complicated primary LASIK and immediate flap amputation, a Lasitome microkeratome (Gebauer, Neuhausen, Germany), equipped with an epi-head and -blade, was used to perform an epi-LASIK surface ablation. RESULTS: Despite uneven stromal contour at the site of the original hinge after amputation of the LASIK flap, the microkeratome passage was uneventful, resulting in a regular epithelial flap. Laser ablation was performed and the epithelial flap was repositioned. CONCLUSIONS: Epi-LASIK was completed with no intraoperative complication in the presence of an irregular stromal surface after amputation of a LASIK flap. This procedure may extend our options in the management of LASIK flap-related complications.

Adult↗

PubMed2005

Mitomycin-C assisted photorefractive keratectomy in the treatment of buttonholed laser in situ keratomileusis flaps associated with epithelial ingrowth.

The prophylactic intraoperative use of mitomycin-C (MMC) to prevent haze and scarring after excimer laser surface ablation (phototherapeutic/photorefractive keratectomy [PTK/PRK]) in an eye with a previous laser in situ keratomileusis (LASIK) flap buttonhole with epithelial ingrowth is described. A well-centered buttonhole measuring 2.0 mm in diameter was cut within a thin LASIK flap in an amblyopic eye. Over the next 8 weeks, corneal haze and progressive epithelial ingrowth formed centrally. An early transepithelial PTK/PRK approach was chosen to manage the buttonhole together with the epithelial ingrowth and to treat ametropia before the onset of scarring. The approach included epithelial removal with PTK, application of MMC 0.02% for 1 minute, irrigation, a short waiting period to allow for diffusion, PRK correction of -4.0 diopters without nomogram adjustment, and bandage contact lens. A regimen of prednisolone acetate 1% and ofloxacin 0.03% 5 times a day for 1 week (steroid tapered) was prescribed. Epithelial ingrowth was removed successfully. Minimal haze formation was visible 2 weeks after the retreatment but did not reduce best spectacle-corrected visual acuity (BSCVA) and resolved within the next few weeks. After 6 weeks, uncorrected visual acuity was equal to BSCVA preoperatively (20/50). There was no evidence of recurrent epithelial ingrowth or central scarring after 24 months. Transepithelial PTK/PRK was effective in managing central epithelial ingrowth in a buttonholed LASIK flap. Prophylactic intraoperative use of MMC may reduce haze formation and corneal scarring in early treatments and may also prevent recurrent epithelial ingrowth. This approach may offer faster visual recovery and no risk for a repeated buttonhole creation compared with the widespread recutting a new flap after a couple of months. The optimal application time and concentration of MMC need to be established.

Adult↗

PubMed2004

Safety, efficacy, and stability indices of LASEK correction in moderate myopia and astigmatism.

PURPOSE: To evaluate the visual outcomes and complications in low to moderate levels of myopia and astigmatism treated with laser-assisted subepithelial keratectomy (LASEK) with a focus on postoperative recovery. SETTING: Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA. METHODS: A retrospective analysis of a case series of eyes treated with LASEK from 1996 to July 2002 with a follow-up of 2 years was performed. The LASEK technique involved creating an epithelial flap with 25 to 45 seconds of exposure to 20% alcohol, ablating the corneal surface using 3 different excimer lasers and nomogram adjustment, and repositioning the flap and applying a bandage contact lens. The main outcome measures were uncorrected visual acuity (UCVA), efficacy index, manifest refraction, best spectacle-corrected visual acuity (BSCVA), safety index, retreatment rate, and complications. RESULTS: One hundred seventy-one eyes (85 right eyes and 86 left eyes) of 105 patients were studied. Preoperatively, the mean spherical equivalent was -2.99 diopters (D) +/- 1.43 (SD) (range -0.38 to -7.75 D) and the mean cylinder, -0.78 +/- 0.73 D. The UCVA ranged from 20/800 to 20/32, and the BSCVA ranged from 20/63 to 20/16; the median was 20/20. One week postoperatively, 96% of eyes had a UCVA of 20/40 or better but definitive visual recovery took more than 4 weeks in some eyes. Approximately 95% of eyes were within +/-1.0 D of emmetropia after 4 to 52 weeks; the remaining 5% did not show major deviations. At 4 to 52 weeks, only 1 eye was overcorrected by more than 1.0 D of manifest refraction. The safety index remained close to 1.0 for the follow-up after 4 weeks. The efficacy index displayed a plateau at 0.9 from 1 month to 1 year. No serious complication (including recurrent erosion syndrome) was encountered. The mean follow-up was 31 weeks, and the retreatment rate was 2.9% up to 2 years of follow-up. CONCLUSIONS: The long-term safety and effectiveness of LASEK for the correction of low to moderate myopia and astigmatism were demonstrated. The treatment effect stabilized after 4 weeks.

Adult↗

PubMed2003

Retinal detachment and phthisis bulbi after implantation of an iris prosthetic system.

We report 2 eyes of 2 patients who developed persistent inflammation, hypotony, and total retinal detachment after secondary implantation of an iris prosthetic system (IPS) in association with cataract surgery. The first patient had an uneventful history of 16 years despite a retained intraocular glass foreign body and the second patient, of 38 years after sustaining penetrating corneoscleral injury with iris tissue loss. Both patients were thoroughly assessed clinically, and the enucleated globe in the first patient was examined by light microscopy. Both eyes had chronic inflammation with retrocorneal and cyclitic membrane formation around the artificial iris-lens diaphragm. These cases suggest that implantation of an IPS combined with cataract surgery can trigger decompensation of posttraumatic eyes that had been stable over a long period.

Adult↗

PubMed2003

LASEK results.

Laser subepithelial keratomileusis (LASEK) has become a viable alternative to photorefractive keratectomy (PRK) and laser in situ keratomileusis (LASIK) in selected patients. LASEK may decrease the complications associated with PRK, including postoperative pain and slow visual rehabilitation. In this article, the authors present the visual outcomes and complication rates of LASEK based on the retrospective case review of 101 consecutive patients (163 eyes) treated with LASEK surgery over the past 6 years. Seventy-eight percent of these eyes showed complete epithelial healing by day 3, and there were no incidents of recurrent erosions. As with LASIK, the achieved correction for LASEK was greater than the treatment dose (requiring undercorrection nomogram adjustments). Mean logMAR UCVA was 0.03 (20/20) at 1 year. LASEK seems to be a safe and effective option for patients who request refractive surgery.

Adult↗

PubMedDate not supplied

Evolution, techniques, clinical outcomes, and pathophysiology of LASEK: review of the literature.

Laser subepithelial keratomileusis (LASEK) is a relatively new laser surgical procedure that combines certain elements of both laser in situ keratomileusis (LASIK) and photorefractive keratectomy (PRK) to improve the risk/benefit ratio. Diluted alcohol is used to loosen the epithelial adhesion to the corneal stroma. The loosened epithelium is moved aside from the treatment zone as a hinged sheet. Laser ablation of the subepithelial stroma is performed before the epithelial sheet is returned to its original position. We reviewed the literature regarding modifications of the technique, indications, outcomes, and complications, as well as wound healing after LASEK surgery. This literature review of 1,421 LASEK-treated eyes provided many findings: 1) The long-term stable results in the absence of serious complications, such as infections, recurrent erosions, scars, or late-onset corneal haze formation in patients re-examined up to 5 years after LASEK; 2) Epithelial closure with recovery of functional vision was completed at days 4 to 7 in most cases; 3) A tendency toward overcorrection with PRK nomograms; 4) We hypothesize that this tendency may be due to the decreased wound healing response, which may lead to myopic regression in PRK; and 5) Postoperative discomfort and prolonged visual recovery until the epithelium closes remain the biggest disadvantages of LASEK compared to LASIK. LASEK surgery is especially valuable in patients with thin corneas who would not qualify for LASIK surgery. However, a potential superiority of LASEK to LASIK in wavefront guided ablations still remains speculative.

Humans↗